NDRA
ENDRA Life Sciences IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$8.21M
P/E Ratio
—
EPS
$-8.16
Beta
-0.11
52W High
$11.96
52W Low
$2.96
50-Day MA
$5.10
200-Day MA
$4.88
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About ENDRA Life Sciences Inc
ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. The company is headquartered in Ann Arbor, Michigan.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-6.43M |
| Operating Margin | 0.00% |
| Return on Equity | -412.60% |
| Return on Assets | -122.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.52 |
| Price-to-Book | 3.19 |
| Price-to-Sales (TTM) | 1838.78 |
| EV/Revenue | 1845.91 |
| EV/EBITDA | -0.11 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $1.85M |
| Float | $1.20M |
| % Insiders | 9.76% |
| % Institutions | 11.13% |
Historical Volatility
HV 10-Day
98.50%
HV 20-Day
91.93%
HV 30-Day
87.50%
HV 60-Day
105.73%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($25.00 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026